BADENOMA recruitment target met 9 months early

Action Medical Research awards £100k for IBD research

Dr Matthias Zilbauer, of the University of Cambridge, has been awarded £100k for a project aiming to find a way to predict how a child’s condition is likely to progress if they are diagnosed with IBD – whether the child’s symptoms are likely to be mild and require minimal treatment, or more severe, needing more intensive treatment

Three new clinical trials - personalising treatment in pancreatic cancer

PRECISION-Panc is an ambitious programme of research that seeks to uncover the molecular profile of individual patients with pancreatic cancer.

IASO trial of anakinra for acute severe ulcerative colitis

Despite huge progress in the outpatient management of ulcerative colitis, there are still around 2,500 admissions for acute severe UC in the UK every year.

METRIC Study closed for recruitment - add-on study funded

The research team were successful in securing £358,183 funding from the HTA for an add on study

Crohn's Disease trial funding success: cine MRI

Joint collaborations between members of the British Society of Gastrointestinal and Abdominal Radiology (BSGAR) and the BSG have led to recent grant success from the NIHR

NIHR Study Support Service Route Map

Planning to deliver a study in the NHS?

New HRA approval leaflet

The Health Research Authority (HRA) has published a new brief leaflet setting out high level information about the HRA Approval process.

New Wilson Disease trial recruiting now

A phase 2, multi-centre, international therapeutic trial has been approved in the UK for patients with Wilson's disease.

Registered Clinical Trials Units

The UK Clinical Research Collaboration (UKCRC) Registered CTU Network is a network of academic clinical trials units (CTUs) that have been assessed by an international panel of experts in clinical trials research.

Can aspirin stop cancer?

The world’s largest ever clinical trial looking at whether taking aspirin every day stops some of the most common cancers coming back launched on 22 October 2015.

Join the PANTS Study!

Inclusion of patients receiving Biosimilar Infliximab - Remsima™ & Inflectra™

HCV clinical trial and tissue biobank

HCV Research UK is a national cohort of over 11,000 patients enrolled between 2012 and 2014 from 60 centres within the UK with evidence of hepatitis C virus infection.

ENDCaP-C Study: Enhanced Neoplasia Detection and Cancer Prevention in Chronic Colitis

CRN West Midlands is the Lead CRN for the ENDCaP-C study (Enhanced Neoplasia Detection and Cancer Prevention in Chronic Colitis: A Multicentre test accuracy study; UKCRN ID: 17739; Chief Investigator: Dr Tariq Iqbal)